Litigation Details for AstraZeneca Pharmaceuticals LP v. Amneal Pharmaceuticals LLC (D. Del. 2015)

✉ Email this page to a colleague

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2015-12-08	1		following patents are listed in the FDA’s Orange Book Byetta®: U.S. Patent Nos. 5,424,286, 6,858,576, 6,956,026…expiration of U.S. Patent Nos. 6,872,700 (the “’700 patent”) and 6,902,744 (the “’744 patent”). …infringement of the ’700 patent and the ’744 patent (collectively, “the asserted patents”). This Court has … This action is for patent infringement, brought pursuant to the patent laws of the United States… This civil action for patent infringement arises under the patent laws of the United States, including	External link to document
2016-06-30	33		Initial Infringement Contentions for U.S. Patent Nos. 6,872,700 and 6,902,744 filed by Amylin Pharmaceuticals… 21 September 2017 1:15-cv-01139 830 Patent None District Court, D. Delaware	External link to document
2016-08-12	38		Initial Invalidity Contentions for U.S. Patent Nos. 6,872,700 & 6,902,744 filed by Amneal Pharmaceuticals… 21 September 2017 1:15-cv-01139 830 Patent None District Court, D. Delaware	External link to document
2015-12-08	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,872,700; 6,902,744;. (sar) … 21 September 2017 1:15-cv-01139 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document